Incannex Healthcare (IXHL) News Today $0.22 +0.01 (+4.42%) Closing price 04:00 PM EasternExtended Trading$0.23 +0.01 (+5.19%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IXHL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Incannex Healthcare Ltd ADR News (IXHL) - Investing.comJuly 3, 2025 | investing.comIXHL - Incannex Healthcare Inc Executives - MorningstarJuly 3, 2025 | morningstar.comMIncannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. KirschJune 24, 2025 | globenewswire.comIncannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42XJune 18, 2025 | globenewswire.comIncannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted TherapyJune 17, 2025 | globenewswire.comIncannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM ExecutionJune 12, 2025 | globenewswire.comIncannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) ProgramJune 3, 2025 | globenewswire.comIncannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline ...May 29, 2025 | morningstar.comMIncannex Healthcare Inc. Finalizes Agreement to Cancel Remaining Series A Warrants, Reducing Potential Dilution by Up to 347.2 Million SharesMay 29, 2025 | nasdaq.comIncannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol ClearanceMay 29, 2025 | globenewswire.comIncannex Cancels Series A Warrants to Strengthen CapitalMay 28, 2025 | tipranks.comIncannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline ResultsMay 28, 2025 | globenewswire.comIncannex Healthcare boosts share offering capacityMay 21, 2025 | uk.investing.comIncannex Cancels Warrants to Strengthen Shareholder PositionMay 20, 2025 | tipranks.comIncannex Healthcare Expands Share Issuance AgreementMay 20, 2025 | tipranks.comIncannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential DilutionMay 20, 2025 | globenewswire.comIncannex Announces Potential Reduction of Up to 50.4% of its Series A WarrantsMay 16, 2025 | globenewswire.comIncannex Healthcare Adjusts Series A Warrants AgreementMay 15, 2025 | tipranks.comIncannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business UpdatesMay 15, 2025 | globenewswire.comIncannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily ...May 14, 2025 | gurufocus.comIncannex Completes Patient Dosing in Phase 2 StudyMay 14, 2025 | tipranks.comIncannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)May 14, 2025 | globenewswire.comIncannex enters agreement for potential stock salesApril 9, 2025 | investing.comIncannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)April 3, 2025 | globenewswire.comIncannex Healthcare Stock Price, Quotes and Forecasts | NASDAQ:IXHL | BenzingaMarch 9, 2025 | benzinga.comIncannex Healthcare Inc. Announces Pricing of $12. ...March 7, 2025 | gurufocus.comIncannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq RulesMarch 7, 2025 | globenewswire.comIncannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business UpdatesFebruary 14, 2025 | globenewswire.comIncannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory BoardFebruary 4, 2025 | globenewswire.comIncannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep ApneaJanuary 23, 2025 | globenewswire.comIncannex Healthcare (NASDAQ:IXHL) Shares Up 5.5% - Still a Buy?November 19, 2024 | marketbeat.comIncannex Healthcare Reports Q3 Loss, Secures New FundingNovember 19, 2024 | markets.businessinsider.comRFK and the 'MAHA Trade': Vaccine makers down, psychedelic shares upNovember 16, 2024 | msn.comIncannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business UpdatesNovember 14, 2024 | globenewswire.comIncannex Healthcare Leads The Charge On US Penny Stocks With 2 Other Notable PicksOctober 24, 2024 | finance.yahoo.comIncannex Announces Appointment of Dr. Lou Barbato as Chief Medical OfficerOctober 24, 2024 | globenewswire.comIncannex Healthcare (NASDAQ:IXHL) Stock, Short Interest ReportOctober 5, 2024 | benzinga.comIncannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business UpdatesSeptember 30, 2024 | globenewswire.comIncannex Healthcare Inc. (NASDAQ:IXHL) Short Interest UpdateSeptember 13, 2024 | marketbeat.comIncannex Healthcare Announces Strategic Financing for up to $60 Million with Arena InvestorsSeptember 10, 2024 | finance.yahoo.comFDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to ProceedAugust 5, 2024 | globenewswire.comTidal Investments LLC Acquires Shares of 423,410 Incannex Healthcare Inc. (NASDAQ:IXHL)August 4, 2024 | marketbeat.comDosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42XJuly 30, 2024 | globenewswire.comIncannex Healthcare Inc. (NASDAQ:IXHL) Sees Significant Growth in Short InterestJuly 26, 2024 | marketbeat.comIncannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Down 69.0% in JuneJuly 11, 2024 | marketbeat.comIncannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Down 32.9% in JuneJune 29, 2024 | marketbeat.comPatient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep ApneaMay 30, 2024 | globenewswire.comIncannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Up 31.3% in AprilMay 15, 2024 | marketbeat.comIncannex Healthcare: Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorderMay 7, 2024 | finanznachrichten.deIncannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorderMay 7, 2024 | globenewswire.com Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Email Address IXHL Media Mentions By Week IXHL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IXHL News Sentiment▼0.000.57▲Average Medical News Sentiment IXHL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IXHL Articles This Week▼20▲IXHL Articles Average Week Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cyclo Therapeutics News FibroBiologics News Klotho Neurosciences News NanoViricides News BioAtla News Synergy CHC News Chemomab Therapeutics News ALX Oncology News VYNE Therapeutics News Ovid Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IXHL) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored$3,200 from your phone?No charts. No crypto. No stock picking. With just a regular brokerage app and Jeff Clark’s “Crossfire” meth...TradeSmith | SponsoredElon brings 'disruption and chaos ' to DCWhat it's really like to work with Elon... "A business partner of mine has close ties to the Department of ...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incannex Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Incannex Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
